Research Roundup: A promising malaria vaccine, a virulent new form of HIV, climate change, and more
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Sign up to receive news and updates from GHTC.
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
As global health advocates, our work often requires us to focus on unmet needs—such as the number of people worldwide who still die from preventable diseases each year, or the lack of adequate resources and investment to tackle these diseases.
In this post, Eoghan Walsh—communications officer at Deutsche Stiftung Weltbevoelkerung (DSW)—writes about the need for Europe to increase financial and political support for efforts aimed at creating new ways to tackle diseases such as HIV and AIDS, tuberculosis (TB) and malaria.
In this post, PATH Vice President of Product Development, David Kaslow, writes about the first-ever shipment of semisynthetic artemisinin (ssART)—a new type of malaria treatment that marks a significant milestone in the fight against malaria.